Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase

Liver International

Volumn 24, Issue 4, 2004, Pages 384-393

  Hatano, Etsuro ^a   Tanaka, Akira ^a   Kanazawa, Akiyoshi ^a   Tsuyuki, Shigeru ^a   Tsunekawa, Shoji ^a   Iwata, Shingo ^a   Takahashi, Rei ^a   Chance, Britton ^b   Yamaoka, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ATP; Caspase 3; Mitochondrial transmembrane potential; Phosphocreatine

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CREATINE KINASE; CREATINE PHOSPHATE; DACTINOMYCIN; DNA FRAGMENT; FAS ANTIBODY; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL FOOD; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; LIVER FAILURE; LIVER INJURY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

EID: 4444336819     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0939.x     Document Type: Article

References (47)

1. Aggarwal B B, Natarajan K. Tumor necrosis factors: development during the last decade. Eur Cytokine Networks 1996; 7: 93-124.
2. Leist M, Gantner F, Bohlinger I, Germann P G, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo- by TNF-α requires transcriptional arrest. J Immunol 1994; 153: 1778-88.
3. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995; 154: 1307-161
4. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann P G, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-34.
5. Richter C, Schweizer M, Cossarizza A, Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett 1996; 378: 107-10.
6. Kroemer G, Zamzami N, Susin S A. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
7. Petit P X, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon M L. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 1995; 130: 157-67.
8. Zamzani N, Marchetti P, Castedo M, Zanin C, Vayssière J, Petit P X, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995; 181: 1661-72.
9. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182: 367-77.
10. Higuchi M, Aggarwal B B, Yeh E T H. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 1997; 99: 1751-8.
11. Meyer R A, Sweeney H L, Kushmerick M J. A simple analysis of the phosphocreatine shuttle. Am J Physiol 1984; 246: C365-77.
12. Hatano E, Tanaka, Iwata S, Satoh S, Kitai T, Tsunekawa S, et al. Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase. Hepatology 1996; 24: 663-9.
13. Satoh S, Tanaka A, Hatano E, Inomoto T, Iwata S, Kitai T, et al. Energy metabolism and regeneration in transgenic mouse liver expressing creatine kinase after major hepatectomy. Gastroentelogy 1996; 110: 1166-74.
14. Kanazawa A, Tanaka A, Iwata S, Satoh S, Hatano E, Shinohara H, et al. The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death. J Surg Res 1998; 80: 229-35.
15. Koretsky A P, Brosnan M J, Chen L, Chen J, Van Dyke T. NMR detection of creatine kinase expressed in liver of transgenic mice: determination of free ADP levels. Proc Natl Acad Sci USA 1990; 87: 3112-6.
16. Walker J B. Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol 1979; 50: 177-242.
17. Yamamoto Y, Obara M, Isselhard W, Sturz J, Morimoto T, Minor T, et al. Rapid determination of the membrane potential of mitochondrial in small biopsy specimens of the liver. Eur Surg Res 1995; 27: 145-50.
18. Modica-Napolitano J S, Weiss M J, Chen L B, Aprille J R. Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria. Biochem Biophys Res Commun 1984; 118: 717-23.
19. Cossarizza A, Ceccarelli, Masini A. functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level. Exp Cell Res 1996; 222: 84-94.
20. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 1996; 184: 2067-72.
21. Enari M, Hase A, Nagata S. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J 1995; 14: 5201-8.
22. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12: 2251-7.
23. Sellevold O F M, Jynge P, Aarstad K. High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol 1986; 18: 517-27.
24. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529-37.
25. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
26. Gantner F, Leist M, Lohse AW, Germann P G, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-8.
27. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effects of the anti-Fas antibody in mice. Nature (London) 1993; 364: 806-9.
28. Nagai H, Shimazawa T, Yakuo I, Aoki M, Koda A, Kasahara M. Role of peptide-leukotrienes in liver injury in mice. Inflammation 1989; 13: 673-80.
29. Smiley S T, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith T W, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 1991; 88: 3671-5.
30. Golstein P. Controlling cell death. Science (Wash. DC) 1997; 275: 1081-2.
31. Stadler J, Benz B G, Harbrecht B G, Silvio M D, Curran R D, Billiar T R, et al. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. Ann Surg 1992; 216: 539-46.
32. Zamzani N, Susin S A, Marchetti P, Hirsch T, Gómez-Monterrey I, Castedo M, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-44.
33. Liu X, Kim C N, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
34. Lopez-Mediavilla C, Orfao A, Gonzales M, Medina J M. Identification by flow cytometry of two distinct rhodamine-123-stained mitochondrial populations in rat liver. FEBS Lett 1989; 254: 115-20.
35. Zoratti M, Szabò I. The mitochondrial permeability transition. Biochim Biophy Acta 1995; 1241: 139-76.
36. Siekevitz P, Potter V R. Biochemical structure of mitochondria; I. Intramitochondrial components and oxidative phosphorylation. J Biol Chem 1955; 215: 221-35.
37. Lehninger A L. Reversal of various types of mitochondrial swelling by adenosine triphosphate. J Biol Chem 1959; 234: 2465-71.
38. Maclennan D H, Tzagoloff A. Studies on the electron transfer system; LXVI. Effect Qf diphosphopyridine nucleotide deficiency on respiration, respiratory control, and phosphorylation in mitochondria. J Biol Chem 1966; 241: 1933-7.
39. Aprille J R. Regulation of the mitochondrial adenine nucleotide pool size in liver: mechanism and metabolic role. FASEB 1 1988; 2: 2547-56.
40. Beyaert R, Fiers W. Molecular mechanism of tumor necrosis factor-induced cytotoxicity; What we do understand and we do not. FEBS Lett 1994; 340: 9-16.
41. Smets L A, Van Den Berg J, Acton D, Top B, Van Rooij H, Verwiss-Janssen M. BCL-2 expression and mitochondrial activity in leukemia cells with different sensitivity to glucocorticoid-induced apoptosis. Blood 1994; 84: 1613-9.
42. Susin S A, Zamzami N, Castedo M, Hirsch T, Marchatti P, Macho A, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184: 1331-41.
43. Wong G H W, Goeddel D W. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 1994; 152: 1751-5.
44. Clement M V, Stamenkovic I. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med 1994; 180: 557-67.
45. Chiu V K, Walsh C M, Liu C C, Reed J C, Clark W R. Bcl-2 blocks degranulation, but not fas-based cell mediated cytotoxicity. J Immunol 1995; 154: 2023-32.
46. Hatano E, Bradham C A, Stark A, Iimuro Y, Lemaster I J, Brenner D A. The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes. J Biol Chem. 2000; 275(16): 11814-23.
47. Bradham C A, Qian T, Streetz K, Trautwein C, Brenner D A, Lemasters J J. The mitochondrial permeability transition is required for tumor necrosis factor alphamediated apoptosis and cytochrome c release. Mol Cell Biol 1998; 18(11): 6353-64.